The Compliance and Digital Information Platform is a web and mobile-based system that creates a real time channel between manufacturers and pharmacies.
“Manufacturers can open up these information channels and distribute content to immediate customers and the whole supply chain,” TraceLink CEO Shabbir Dahod told in-PharmaTechnologist.
“TraceLink has broken new ground with this application, addressing a critical information gap that has existed for decades between pharmaceutical companies, pharmacists and patients,” he said.
Over time, the company hopes to leverage that channel for more bidirectional communication from the pharmacy back to the manufacturer, said Dahod.
The CEO said many of his pharmaceutical clients currently share information via paper based systems.
He explained that while drug manufacturers may have websites, which enable pharmacists and doctors to access product information, this paperless model will allow for greater interaction.
“Through this model, drug companies are able to use more of the internet, animations and videos to enrich that form of communication that goes down to the pharmacies and the pharmacist,” said Dahod.
From a sales viewpoint, the technology will enable pharmacies in the EU to comply with verification and decommissioning requirements, and offers up-to-date information on medicine scans, expiry dates, dispensation trends and product inventory.
The EU Falsified Medicines Directive (EUFMD) will enforce serialisation regulations in Europe in 2019.